$99 — pay once, own it forever
Lifetime access, no subscription →
ScreenerHero
Home
Screener
Charts
Compare
Groups
Maps
Watchlists
·
Pricing
Blog
$
Create free account
Sign in
ESPR
Esperion Therapeutics, Inc.
Share
Alerts
Portfolio
Watchlist
NAS
· US
·
Healthcare
·
Drug Manufacturers - Specialty & Generic
3.180
USD
0.00%
Mkt Cap:
819.46M $
P/E:
Infinity
85d ago
ESPR
Esperion Therapeutics, Inc.
3.180
USD
0.00%
Share
Alerts
Portfolio
Watchlist
Industry Peers
Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.30B
USD
P/E 25.0
TAK
Takeda Pharmaceutical Company Limited
$56.90B
USD
TEVA
Teva Pharmaceutical Industries Limited
$46.26B
USD
P/E 66.1
HLN
Haleon plc
$38.79B
USD
P/E 18.0
ZTS
Zoetis Inc.
$29.51B
USD
P/E 11.7
ZOE
Zoetis Inc.
$28.27B
USD
P/E 12.1
UTHR
United Therapeutics Corporation
$23.01B
USD
P/E 19.2
VTRS
Viatris Inc.
$20.24B
USD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.14B
USD
P/E 110.6
NBIX
Neurocrine Biosciences, Inc.
$14.66B
USD
P/E 21.1
IPN
Ipsen S.A.
$12.60B
USD
P/E 22.8
ELAN
Elanco Animal Health Incorporated
$11.25B
USD
RDY
Dr. Reddy's Laboratories Limited
$10.26B
USD
P/E 28.0
KRK
Krka, d. d.
$8.59B
USD
P/E 19.2
ALKS
Alkermes plc
$7.17B
USD
P/E 112.5
AMRX
Amneal Pharmaceuticals, Inc.
$7.09B
USD
P/E 41.5
HIMS
Hims & Hers Health, Inc.
$6.92B
USD
LNTH
Lantheus Holdings, Inc.
$6.54B
USD
P/E 24.3
KNSA
Kiniksa Pharmaceuticals International, plc
$5.87B
USD
P/E 77.1
APTX
Apotex Health Corp.
$5.17B
USD
Overview
Financials
Analysis
News
Headline
Source
Time
Older
Esperion Therapeutics Clears Key Hurdle as Stockholders Approve Essence Merger
MarketBeat
Jul 10